Topic Review
Diagnosis of Retroperitoneal Sarcoma
Soft tissue sarcomas (STS) are an uncommon and biologically heterogeneous group of tumors arising from mesenchymal cells. The incidence is estimated at five cases per 100,000 people per year. Retroperitoneal sarcomas (RPS) account for 10–15% of all STS, and their management depends on their anatomical characteristics and histotype. Due to their very low incidence, it is recommended that RPS be treated in reference centers and evaluated by an experienced multidisciplinary team (MDT). In Spain, the Spanish Group for Research in Sarcomas (GEIS) brings together experts from various specialties to promote research on sarcomas and improve treatment results.
  • 289
  • 25 Sep 2023
Topic Review
Local Antibiotic Carriers in Prosthetic Joint Infection
Prosthetic Joint Infection (PJI) causes significant morbidity and mortality for patients globally. Delivery of antibiotics to the site of infection has potential to improve the treatment outcomes and enhance biofilm eradication. These antibiotics can be delivered using an intra-articular catheter or combined with a carrier substance to enhance pharmacokinetic properties. Use of an antibiotic carrier is an alternative method of maintaining high local concentrations of antibiotic without systemic exposure. These substances incorporate an antimicrobial to prolong its half-life and provide predictable elution characteristics. They may also serve additional roles, such as filling dead space and providing mechanical support for limb alignment. The ideal antibiotic carrier would provide prolonged antibiotic concentrations at an effective level and achieve complete antibiotic release to minimise subtherapeutic elution time. It would also be versatile and have compatibility with the desired antibiotics, and fully resorbable with minimal risk of allergies, and systemic or local adverse effects.
  • 444
  • 25 Sep 2023
Topic Review
Bile Acids in Intrahepatic Cholestasis of Pregnancy
Intrahepatic cholestasis of pregnancy (ICP) is the most common, reversible, and closely related to pregnancy condition characterized by elevated levels of bile acids (BAs) in blood serum and an increased risk of adverse perinatal outcomes. Due to the complex interactions between the mother and the fetus in metabolism and transplacental BAs transport, ICP is classified as a fetal-maternal disease. The disease is usually mild in pregnant women, but it can be fatal to the fetus, leading to numerous complications, including intrauterine death. The pathophysiology of the disease is based on inflammatory mechanisms caused by elevated BA levels.
  • 288
  • 25 Sep 2023
Topic Review
Dietary HDAC2i in Breast Cancer
Breast cancer (BC) is a lethal malignancy with high morbidity and mortality but lacks effective treatments thus far. Histone deacetylases 2 (HDAC2) inhibitor (HDAC2i) has been proven to exhibit an anti-cancer effect, can act as a sensitizer for immune checkpoint inhibitors (ICIs) therapy. Simultaneously, dietary intervention, as a crucial supportive therapy, has been reported to provide ingredients containing HDAC2 inhibitory activity. Thus, the novel integration of dietary intervention with ICIs therapy may offer promising possibilities for improving treatment outcomes. 
  • 247
  • 25 Sep 2023
Topic Review
Decoys in Cardiovascular Diseases Therapeutic
Cardiovascular disease (CVD) is the main cause of global death, highlighting the fact that conventional therapeutic approaches for the treatment of CVD patients are insufficient, and there is a need to develop new therapeutic approaches. In recent years, decoy technology, decoy oligodeoxynucleotides (ODN), and decoy peptides show promising results for the future treatment of CVDs. Decoy ODN inhibits transcription by binding to the transcriptional factor, while decoy peptide neutralizes receptors by binding to the ligands.
  • 220
  • 25 Sep 2023
Topic Review
The Role of Cholangioscopy in Biliary Diseases
Endoscopy plays a central role in diagnostic and therapeutic approaches to biliary disease in both benign and malignant conditions. A cholangioscope is an endoscopic instrument that allows for the direct exploration of the biliary tree. Cholangioscopy has demonstrated excellent performance in discriminating malignant conditions (such as colangiocarcinoma) from benign inflammatory strictures, and more advances (e.g., artificial intelligence and confocal laser endomicroscopy) could further increase its diagnostic accuracy. Cholangioscopy also plays a primary role in the treatment of benign conditions such as difficult bile stones (DBSs). 
  • 154
  • 25 Sep 2023
Topic Review
Changes in Gut Microbiome and Pathologies in Pregnancy
Pregnancy is a special period in a woman’s life when her organism undergoes multiple physiological changes so that the fetus has optimal conditions for growth and development. These include modifications in the composition of the microbiome that occur between the first and third trimesters of pregnancy. There is an increase in Akkermansia, Bifidobacterium, and Firmicutes, which have been associated with an increase in the need for energy storage. The growth in Proteobacteria and Actinobacteria levels has a protective effect on both the mother and the fetus via proinflammatory mechanisms.
  • 253
  • 25 Sep 2023
Topic Review
GLP-1 and DPP-4  Applied Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is a disorder defined as carbohydrate intolerance that manifests during the second or third trimester of pregnancy. To prevent them, it is important to keep glucose levels under control. As much as 15–30% of GDM patients will require treatment with insulin, metformin, or glyburide. With that in mind, it is crucial to keep searching for novel and improved pharmacotherapies. Nowadays, there are ongoing studies investigating the use of other groups of drugs that have proven successful in the treatment of type 2 diabetes mellitus (T2DM). Glucagon-like peptide-1 (GLP-1) receptor agonist and dipeptidyl peptidase-4 (DPP-4) inhibitor are among the drugs targeting the incretin system and are currently receiving significant attention. GLP-1 is a peptide that is produced through the proteolysis of proglucagon, a protein expressed in L cells in the intestinal mucosa, α cells of the pancreas, as well as in the nucleus of the solitary tract (NTS) in the brainstem. GLP-1 has access to a specific GLP-1 receptor (GLP-1R) that is expressed in a wide range of target tissues. It is secreted mainly after the ingestion of glucose, lipids, or mixed meals, and increases glucose-stimulated insulin secretion at physiological plasma concentrations, which meets all the criteria for an incretin hormone.
  • 126
  • 25 Sep 2023
Topic Review
Therapeutic Applications of Probiotics
Probiotics are live microorganisms that induce health benefits to the host. Prebiotics, such as inulin and fructooligosaccharides, are nondigestible food components that promote the growth of beneficial bacteria in the colon, whereas synbiotics are a mixture of live microorganisms with substrates that are selectively utilized by host which can provide even more benefits than prebiotics alone.
  • 240
  • 25 Sep 2023
Topic Review
Biomolecules in Vascular Endothelial Growth Factor
Vascular endothelial growth factor (VEGF) is a protein belonging to the VEGF family, which is a large group of molecules consisting of VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and placental growth factor (PlGF). VEGF is a subfamily of growth factors (GF). VEGF is a multitasking protein that mediates both vasculogenesis (the process of blood vessel formation from endothelial progenitor cells in embryos and adults during tumor growth) and angiogenesis (the formation of blood vessels from pre-existing vessels formed during vasculogenesis, consisting of sprouting and splitting).
  • 197
  • 25 Sep 2023
  • Page
  • of
  • 1349
Video Production Service